Perry C - Search Results

1

Dual anti-viral treatment for persistent COVID-19 in immunocompromised hemato-oncological patients is associated with a favorable prognosis and minor side effects.

Meijer SE, Halutz O, Adler A, Levytskyi K, Tau L, Dekel M, Cohen-Poradosu R, Katchman E, Shasha D, Ablin J, Choshen G, Jacob G, Wasserman A, Ingbir M, Cohen YC, Perry C, Ram R, Herishanu Y, Bar On Y, van Thijn E, Rutsinsky N, Harari S, Stern A, Ben-Ami R, Paran Y. Meijer SE, et al. Among authors: perry c. J Infect Chemother. 2024 Mar;30(3):271-275. doi: 10.1016/j.jiac.2023.10.022. Epub 2023 Nov 7. J Infect Chemother. 2024. PMID: 37944697

2

Early-mid treatment C-reactive protein level is a prognostic factor in aggressive non-Hodgkin's lymphoma.

Herishanu Y, Perry C, Braunstein R, Metser U, Goor O, Rogowski O, Berliner S, Polliack A, Naparstek E. Herishanu Y, et al. Among authors: perry c. Eur J Haematol. 2007 Aug;79(2):150-4. doi: 10.1111/j.1600-0609.2007.00894.x. Eur J Haematol. 2007. PMID: 17635239

3

Diagnostic accuracy of PET/CT in patients with extranodal marginal zone MALT lymphoma.

Perry C, Herishanu Y, Metzer U, Bairey O, Ruchlemer R, Trejo L, Naparstek E, Sapir EE, Polliack A. Perry C, et al. Eur J Haematol. 2007 Sep;79(3):205-9. doi: 10.1111/j.1600-0609.2007.00895.x. Epub 2007 Jul 27. Eur J Haematol. 2007. PMID: 17662066

4

Fluorine-18 fluorodeoxyglucose PET/CT patterns of extranodal involvement in patients with Non-Hodgkin lymphoma and Hodgkin's disease.

Even-Sapir E, Lievshitz G, Perry C, Herishanu Y, Lerman H, Metser U. Even-Sapir E, et al. Among authors: perry c. Radiol Clin North Am. 2007 Jul;45(4):697-709, vii. doi: 10.1016/j.rcl.2007.05.009. Radiol Clin North Am. 2007. PMID: 17706534 Review.

5

Complete spontaneous regression of chronic lymphocytic leukemia.

Herishanu Y, Solar I, Ben-Ezra J, Cipok M, Meirsdorf S, Amariglio N, Hoffman S, Kay S, Aharon Z, Perry C, Polliack A, Naparstek E. Herishanu Y, et al. Among authors: perry c. J Clin Oncol. 2012 Sep 10;30(26):e254-6. doi: 10.1200/JCO.2011.40.7536. Epub 2012 May 29. J Clin Oncol. 2012. PMID: 22649129 No abstract available.

6

Divergence in CD19-mediated signaling unfolds intraclonal diversity in chronic lymphocytic leukemia, which correlates with disease progression.

Herishanu Y, Kay S, Dezorella N, Baron S, Hazan-Halevy I, Porat Z, Trestman S, Perry C, Braunstein R, Deutsch V, Polliack A, Naparstek E, Katz BZ. Herishanu Y, et al. Among authors: perry c. J Immunol. 2013 Jan 15;190(2):784-93. doi: 10.4049/jimmunol.1200615. Epub 2012 Dec 12. J Immunol. 2013. PMID: 23241880

7

Paradoxical immune reconstitution inflammatory syndrome associated with rituximab-containing regimen in a patient with lymphoma.

Canaani J, Amit S, Ben-Ezra J, Cohen Pour M, Sarid N, Lerman H, Perry C, Polliack A, Naparstek E, Herishanu Y. Canaani J, et al. Among authors: perry c. J Clin Oncol. 2013 Apr 10;31(11):e178-80. doi: 10.1200/JCO.2012.43.6188. Epub 2013 Feb 25. J Clin Oncol. 2013. PMID: 23439758 No abstract available.

8

Absolute monocyte count trichotomizes chronic lymphocytic leukemia into high risk patients with immune dysregulation, disease progression and poor survival.

Herishanu Y, Kay S, Sarid N, Kohan P, Braunstein R, Rotman R, Deutsch V, Ben-Ezra J, Naparstek E, Perry C, Katz BZ. Herishanu Y, et al. Among authors: perry c. Leuk Res. 2013 Oct;37(10):1222-8. doi: 10.1016/j.leukres.2013.07.017. Epub 2013 Aug 9. Leuk Res. 2013. PMID: 23937985

9

Reduced-dose ICE chemotherapy ± rituximab is a safe and effective salvage therapy for fit elderly patients with diffuse large B-cell lymphoma.

Sarid N, Joffe E, Gibstein L, Avivi I, Polliack A, Perry C, Herishanu Y. Sarid N, et al. Among authors: perry c. Leuk Lymphoma. 2016 Jul;57(7):1633-9. doi: 10.3109/10428194.2015.1106532. Epub 2015 Dec 8. Leuk Lymphoma. 2016. PMID: 26643787

10

Fluorine-18 Fluorodeoxyglucose PET/CT Patterns of Extranodal Involvement in Patients with Non-Hodgkin Lymphoma and Hodgkin's Disease.

Even-Sapir E, Lievshitz G, Perry C, Herishanu Y, Lerman H, Metser U. Even-Sapir E, et al. Among authors: perry c. PET Clin. 2006 Jul;1(3):251-63. doi: 10.1016/j.cpet.2006.04.007. Epub 2006 Jun 30. PET Clin. 2006. PMID: 27157364 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,226 results

Search Page